Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor.

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

A typical CGM detects glucose levels in the interstitial fluid with an enzyme-based sensor. The sensor converts glucose ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

An automated insulin delivery (AID) system boosted glycemic control in insulin-treated adults with type 2 diabetes using ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

During the study, the team of researchers analysed the effectiveness of CGM devices for reducing hypoglycaemia in insulin-treated drivers with diabetes. As part of the trial, the participants used a ...

Data from the Barbara Davis Center for Diabetes at University of Colorado show pilots with type 1 diabetes are not just ...